1-2 of 2
Julie Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 3 Study to Evaluate the Efficacy and Safety of Caplacizumab without First-Line Therapeutic Plasma Exchange in Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Sriya Gunawardena, Angela Hu, Laurel A. Menapace, Hikaru Okada, Beverly Accomando, Julie Lin
Journal: Blood
Blood (2022) 140 (Supplement 1): 2770–2771.
https://doi.org/10.1182/blood-2022-156304
Published: 2022
Journal Articles

Long-Term Safety and Efficacy of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (aTTP): The Post-HERCULES Study

Marie Scully, Javier de la Rubia, Katerina Pavenski, Ara Metjian, Paul Knoebl, Flora Peyvandi, Spero Cataland, Paul Coppo, Johanna A. Kremer Hovinga Strebel, Jessica Minkue Mi Edou, Rui de Passos Sousa, Filip Callewaert, Sriya Gunawardena, Julie Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2080.
https://doi.org/10.1182/blood-2021-148839
Published: 2021